Trial Profile
A Single-center, Open, Phase I Clinical Trial to Evaluate Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Shigella dysenteriae vaccine (Primary)
- Indications Dysentery
- Focus Adverse reactions
- Sponsors Beijing Zhifei Lvzhu Biopharmaceutical
- 11 Sep 2018 Status changed from active, no longer recruiting to completed.
- 27 Jun 2018 New trial record